Siva Therapeutics Selected as a Company to Watch at the Angel Capital Summit in Denver, CO

BOULDER, COLORADO, April 4, 2012–Siva Therapeutics was selected as a company to watch by a panel of investors at the Angel Capital Summit (ACS) in Denver, CO. Out of 40 presenting companies, Siva Therapeutics was one of 13 companies selected to the watch list by investors during the Denver Investor Forum that took place following the ACS presentations.The watch list was a designation for companies that received high interest from the Angel Investors present during the forum.

“We are very pleased with the result of our efforts at the Angel Capital Summit this year, and to be selected as one of the companies to watch by investors,” said Len Pagliaro, PhD, CEO of Siva. “We are actively engaging investors that are interested in participating in the early growth of Siva and our development of effective treatments for skin cancer using our patented technology.” The ACS is a three day event at the University of Denver designed to connect investors with entrepreneurs, hosted by the Rockies Venture Club, Colorado’s oldest and most influential venture capital organization. The ACS has been providing financing to entrepreneurs in the Rocky Mountain region since 2007. Approximately 150 applications to present at this year’s ACS were received for the 40 presentation slots available.

About Siva Therapeutics Inc

Siva Therapeutics Inc is an early stage biotechnology company developing a photothermal device cancer therapy which uses heat to irreversibly damage solid tumor tissue. The heat is delivered to tumors by infrared light that is absorbed by gold nanoparticles and re-emitted as heat. The size, shape, and surface chemistry of the particles target the leaky vasculature of solid tumors, and the selective thermal sensitivity of tumor tissue enables the therapy to deliver clean margins. Siva therapy is extremely safe, effective, and competitive in cost relative to surgery, chemotherapy, and radiation for cancer treatment. For more information please visit: www.sivatherapeutics.com.

Media Contact: info@sivatherapeutics.com

About the Angel Capital Summit 2012

Sponsored by Rockies Venture Club, a 501(c) 6 not-for-profit membership organization serving investors, entrepreneurs and service providers since 1983, the Angel Capital Summit now enters its fifth year as one of the largest events of its kind in the nation. The Angel Capital Summit 2012 was designed with one purpose in mind – to connect entrepreneurs with the capital they need to grow their business. For more information please visit: www.angelcapitalsummit.org.

About the Rockies Venture Club

Since 1985, the Rockies Venture Club has connected entrepreneurs with angel investors, venture capitalists, service professionals, and other business and funding resources. One of the nation’s first non-profits devoted exclusively to helping entrepreneurs launch and manage companies with high growth potential, the Rockies Venture Club offers its members: This goal is accomplished with a 1-2-3 approach of education, connection and execution. For more information please visit: www.rockiesventureclub.org

PDF version of this article: April 4, 2012 – Siva Therapeutics Selected as a Company to Watch at the Angel Capital Summit in Denver, CO